Insider Selling: Maria Bedoya-Toro Unloads 10,000 Shares of Santarus Stock (SNTS)
Santarus (NASDAQ:SNTS) SVP Maria Bedoya-Toro sold 10,000 shares of Santarus stock in a transaction that occurred on Tuesday, October 8th. The stock was sold at an average price of $21.39, for a total value of $213,900.00. Following the sale, the senior vice president now directly owns 48,695 shares of the company’s stock, valued at approximately $1,041,586. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Shares of Santarus (NASDAQ:SNTS) traded up 1.28% on Wednesday, hitting $21.32. 2,148,784 shares of the company’s stock traded hands. Santarus has a one year low of $8.47 and a one year high of $28.10. The stock’s 50-day moving average is $22.67 and its 200-day moving average is $21.82. The company has a market cap of $1.415 billion and a price-to-earnings ratio of 14.67.
Santarus (NASDAQ:SNTS) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.76. The company had revenue of $89.40 million for the quarter, compared to the consensus estimate of $82.90 million. During the same quarter in the previous year, the company posted $0.05 earnings per share. The company’s revenue for the quarter was up 89.4% on a year-over-year basis. On average, analysts predict that Santarus will post $1.26 earnings per share for the current fiscal year.
SNTS has been the subject of a number of recent research reports. Analysts at Ned Davis Research initiated coverage on shares of Santarus in a research note to investors on Monday. They set a “neutral” rating on the stock. Separately, analysts at Leerink Swann downgraded shares of Santarus from an “outperform” rating to a “market perform” rating in a research note to investors on Thursday, August 22nd. They now have a $26.00 price target on the stock. They noted that the move was a valuation call. Finally, analysts at JMP Securities raised their price target on shares of Santarus from $27.00 to $31.00 in a research note to investors on Wednesday, August 7th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $25.63.
Santarus, Inc (NASDAQ:SNTS) is a specialty biopharmaceutical company focused on acquiring, developing and commercializing products that address the needs of patients treated by physician specialists.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.